Programmed cell death-1 (PD-1)/PD-L1 ligand 1 (PD-L1) (CD279) is an inhibitory checkpoint, which can inhibit the activation of T and B cells in the tumor microenvironment [32]. The gene discussed is PDCD1; the disease is neoplasm.